International Assets Investment Management LLC lifted its position in shares of Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 3,953.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 156,532 shares of the rocket manufacturer's stock after buying an additional 152,670 shares during the period. International Assets Investment Management LLC's holdings in Rocket Lab were worth $10,907,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in RKLB. Lebenthal Global Advisors LLC purchased a new stake in shares of Rocket Lab during the 3rd quarter worth about $265,000. CHICAGO TRUST Co NA acquired a new stake in Rocket Lab during the 3rd quarter worth approximately $202,000. Parcion Private Wealth LLC raised its holdings in Rocket Lab by 20.8% in the third quarter. Parcion Private Wealth LLC now owns 3,958 shares of the rocket manufacturer's stock valued at $276,000 after buying an additional 681 shares during the period. Partners Wealth Management LLC purchased a new position in Rocket Lab in the third quarter valued at approximately $1,060,000. Finally, Soltis Investment Advisors LLC lifted its position in Rocket Lab by 8.7% during the third quarter. Soltis Investment Advisors LLC now owns 3,867 shares of the rocket manufacturer's stock valued at $269,000 after buying an additional 310 shares in the last quarter. 71.78% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Rocket Lab
In other news, CFO Adam C. Spice sold 140,157 shares of Rocket Lab stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the sale, the chief financial officer directly owned 1,155,967 shares of the company's stock, valued at approximately $81,865,582.94. The trade was a 10.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Agostino Ricupati sold 669 shares of the business's stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the completion of the transaction, the chief accounting officer owned 26,863 shares in the company, valued at approximately $1,870,470.69. This trade represents a 2.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 400,749 shares of company stock worth $26,964,474 over the last three months. Insiders own 8.40% of the company's stock.
Rocket Lab News Summary
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
- Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
- Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
- Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
- Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay
Rocket Lab Stock Down 7.4%
Shares of NASDAQ:RKLB opened at $54.73 on Friday. The company has a market capitalization of $32.75 billion, a price-to-earnings ratio of -202.70 and a beta of 2.93. The company has a 50 day moving average of $64.23 and a two-hundred day moving average of $79.93. Rocket Lab Corporation has a 52-week low of $37.57 and a 52-week high of $151.00. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). The firm had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. As a group, analysts forecast that Rocket Lab Corporation will post -0.20 earnings per share for the current fiscal year.
Analyst Ratings Changes
RKLB has been the subject of several research reports. KGI Securities upgraded shares of Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 price objective for the company in a research note on Monday, July 27th. Morgan Stanley reissued an "overweight" rating on shares of Rocket Lab in a research note on Wednesday, July 8th. Roth Capital reaffirmed a "buy" rating on shares of Rocket Lab in a research report on Thursday, October 15th. Cantor Fitzgerald reiterated a "mixed" rating and issued a $122.00 price target on shares of Rocket Lab in a report on Thursday, October 15th. Finally, KeyCorp cut their price objective on Rocket Lab from $135.00 to $100.00 and set an "overweight" rating on the stock in a research report on Thursday, October 15th. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $102.05.
Read Our Latest Analysis on Rocket Lab
Rocket Lab Company Profile
(
Free Report)
Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.
Rocket Lab's launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.
Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.